What is the market capitalization of Vor Biopharma Inc.?

Vor Biopharma Inc. (VOR) has a market capitalization of approximately 728,258,187 USD.

Where can I buy VOR in Canada?

VOR can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

VOR

Vor Biopharma Inc.

Vor Biopharma Inc. (VOR) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 728 million USD (small-cap).

Details

Price13.44 USD

Market cap728.26 M USD

Payout ratio0.00%

SectorHealthcare

Websitevorbio.com

Updated 1h ago

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.